The Office for Life Sciences has launched the £20 million Addiction Healthcare Goals – Catalysing Innovation Awards, delivered by Innovate UK, to fast-track the development of innovative pharmaceutical, MedTech and digital technologies for tackling drug and alcohol addiction healthcare challenges.
Full story here 👉 Supporting innovation in drug and alcohol addiction healthcare challenges – Innovate UK Business Connect
Open to applications until 6th May, the competition features two strands to support innovations at different stages:
- The Advancing innovation in drug and alcohol addiction healthcarestrand is focused on innovations capable of demonstrating proof of real‑world efficacy and strong UK market readiness by the end of the project. Three year projects from industry-led consortia ranging in size from £250,000 up to £10m are eligible for grants.
- The Contracts for Innovation in drug and alcoholstrand is targeted at innovations with the potential to demonstrate initial efficacy and UK market fit by the end of the project. Two year projects of between £200,000 and £1.5m can secure fully funded awards.
ℹ️ Register now for an online briefing event on 19th February 15:00-16:00 for further details on scope and how to apply
Successful applicants will be secure exclusive access to a Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care Excellence (NICE) education session to understand evidence requirements, stakeholder engagement and key steps towards UK market readiness and reimbursement.
